Skip to content

Common Stock at other companies

Halozyme Therapeutics logo
Halozyme TherapeuticsHALO
300M0.0%
Viatris logo
ViatrisVTRS
3B
Opko Health logo
Opko HealthOPK
$7.85M+11.9%
AptarGroup logo
AptarGroupATR
199M0.0%
ARS Pharmaceuticals, Inc. logo
ARS Pharmaceuticals, Inc.SPRY
$10K0.0%
Amneal Pharmaceuticals, Inc. logo
Amneal Pharmaceuticals, Inc.AMRX
$10

Other financials

Income statement

See full
Revenue$171.2M+0.4%
Gross profit$70.3M-17.5%
Operating income$13.6M-63.5%
Net income$6.4M-74.6%
EPS (diluted)$0.14-72.5%

Balance sheet

See full
Cash & equivalents$170.9M-6.5%
Total debt$686.6M+5.2%
Total equity$445.5M
Total assets$1.6B+1.3%

Cash flow

See full
Operating cash flow$47.8M+36.4%
CapEx$9.5M-11.1%
Free cash flow$38.3M+57.2%

Valuation

See full
Market cap$926.83M-19.9%
Enterprise value$1.44B-11.3%
P/E11.7×+3.5×
P/S1.3×-0.3×

Profitability

See full
Gross margin47.3%-3.2pp
Operating margin16.2%-10.4pp
Net margin11%-8.4pp
FCF margin18.8%-1.8pp

Returns & leverage

See full
Return on equity14.7%
Debt / equity0.2×
Current ratio3.9×+0.9×

Where this comes from

Reported directly by Amphastar Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:CommonStockValue.

The official record: Amphastar Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Amphastar Pharmaceuticals's common stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Amphastar Pharmaceuticals's common stock?
Amphastar Pharmaceuticals (AMPH) reported common stock of $6K in Q1 2026.
How has Amphastar Pharmaceuticals's common stock changed year-over-year?
Amphastar Pharmaceuticals's common stock decreased by 0.0% year-over-year, from $6K to $6K.
What is the long-term trend for Amphastar Pharmaceuticals's common stock?
Over 5 years (2020 to 2025), Amphastar Pharmaceuticals's common stock has grown at a 3.7% compound annual growth rate (CAGR), from $5K to $6K.
What does common stock mean?
The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).